Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Vertex Pharmaceuticals 3.334, Abbott Laboratories 12.593.
Vertex Pharmaceuticals vs Abbott Laboratories Net Worth and Market Cap
Vertex Pharmaceuticals (VRTX) and Abbott Laboratories (ABT) are peers in Healthcare. Vertex Pharmaceuticals reported revenue of $3.3B as of Q2 2026, compared with $12.6B for Abbott Laboratories. Abbott Laboratories leads on revenue.
Vertex Pharmaceuticals's gross margin is 85.3% versus 58.0% for Abbott Laboratories. Vertex Pharmaceuticals's net margin is 33.0% versus 7.4% for Abbott Laboratories.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Vertex Pharmaceuticals, Abbott Laboratories.| Metric | Vertex Pharmaceuticals | Abbott Laboratories |
|---|---|---|
| Market Cap | - | - |
| Revenue | $3.33B | $12.59B |
| Cost of Revenue | $489.00M | $5.29B |
| Gross Profit | $2.85B | $7.30B |
| Operating Income | $1.25B | $1.78B |
| Net Income | $1.10B | $928.00M |
| R&D Expense | $994.00M | $882.00M |
| Earnings Per Share | $4.31 | $0.53 |
| Gross Margin | 85.3% | 58.0% |
| Operating Margin | 37.4% | 14.2% |
| Net Profit Margin | 33.0% | 7.4% |
| Free Cash Flow | $1.01B | $2.89B |
| Cumulative Free Cash Flow | $17.24B | $142.48B |
| Operating Cash Flow | $1.13B | $2.49B |
| Cash & Equivalents | $6.14B | $5.10B |